CLINICAL TRIALS PROFILE FOR CLORAZEPATE DIPOTASSIUM
✉ Email this page to a colleague
All Clinical Trials for CLORAZEPATE DIPOTASSIUM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00775996 ↗ | Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2003-08-01 | The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions. |
NCT04726592 ↗ | Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room | Recruiting | Assistance Publique - Hôpitaux de Paris | Phase 3 | 2021-07-08 | The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLORAZEPATE DIPOTASSIUM
Condition Name
Clinical Trial Locations for CLORAZEPATE DIPOTASSIUM
Trials by Country
Clinical Trial Progress for CLORAZEPATE DIPOTASSIUM
Clinical Trial Phase
Clinical Trial Sponsors for CLORAZEPATE DIPOTASSIUM
Sponsor Name